Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | DRD1 | P21728 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | DRD3 | P35462 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8584337 | 0.89 | — | — | |
| SCHEMBL7619830 | 0.86 | KDM4E (0.36) | SMN1; SMN2KDM4ECHRM2ADRA2ACHRM1 | |
| SCHEMBL152779 | 0.82 | TDP1 (0.40) | KDM4ETDP1LMNAKMT2AAPOBEC3A | |
| SCHEMBL10211088 | 0.82 | TDP1 (0.40) | KDM4ETDP1LMNAKMT2AAPOBEC3A | |
| SCHEMBL16203348 | 0.82 | TDP1 (0.40) | KDM4ETDP1LMNAKMT2AAPOBEC3A | |
| SCHEMBL8432760 | 0.79 | HRH3 (0.33) | KCNH2CYP2D6CYP3A4 | |
| SCHEMBL23666391 | 0.79 | DRD1 (0.39) | CHRM2ADRA2ACHRM1DRD1OPRM1 | |
| SCHEMBL1351072 | 0.79 | HRH3 (0.33) | KCNH2CYP2D6CYP3A4 | |
| SCHEMBL82606 | 0.78 | — | — | |
| SCHEMBL7542075 | 0.78 | TDP1 (0.44) | KDM4ETDP1LMNAKMT2AAPOBEC3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210222294-A1 | METAL TRIAMINE COMPOUND, METHOD FOR PREPARING THE SAME, AND COMPOSITION FOR DEPOSITING METAL-CONTAINING THIN FILM INCLUDING THE SAME | DNF CO., LTD. (KR) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210222294-A1 | METAL TRIAMINE COMPOUND, METHOD FOR PREPARING THE SAME, AND COMPOSITION FOR DEPOSITING METAL-CONTAINING THIN FILM INCLUDING THE SAME | ASH2L, TRMT1, SETDB1 | SMN1; SMN2 1447/4885KDM4E 447/4885CHRM2 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.